Entamoeba
Entamoeba is a genus of amoeboid protozoa that are known for their ability to cause disease in humans and other animals. The most well-known species within this genus is Entamoeba histolytica, which is the causative agent of amoebiasis, also known as amoebic dysentery. This condition primarily affects the intestines and can lead to severe diarrhea, abdominal pain, and in extreme cases, can be fatal if not properly treated. Other species within the genus, such as Entamoeba dispar and Entamoeba coli, are generally non-pathogenic and reside in the intestine without causing disease.
Classification and Structure[edit | edit source]
Entamoeba belongs to the phylum Amoebozoa, which comprises amoeboid cells that move and capture food by extending finger-like projections of their cell membrane, known as pseudopods. The Entamoeba species are characterized by their simple, unicellular structure, with a clear distinction between the granular endoplasm and the transparent ectoplasm. They reproduce asexually through a process known as binary fission.
Life Cycle[edit | edit source]
The life cycle of Entamoeba histolytica involves two stages: the trophozoite and the cyst. The trophozoite is the active, feeding, and dividing stage, which resides in the host's large intestine. The cyst stage is the infective form; it is excreted in the feces and can survive outside the host in a moist environment. Transmission occurs through ingestion of contaminated food or water containing cysts, leading to infection.
Pathogenesis and Clinical Features[edit | edit source]
Entamoeba histolytica invades the intestinal lining, causing ulcers, bleeding, and in severe cases, perforation of the colon. It can also spread to other organs, most notably the liver, leading to amoebic liver abscesses. Symptoms of amoebiasis include severe diarrhea, abdominal pain, and weight loss. Diagnosis is typically made by identifying cysts or trophozoites in stool samples or by serological tests.
Treatment and Prevention[edit | edit source]
Treatment for amoebiasis involves the use of anti-amoebic medications, such as metronidazole or tinidazole, followed by a luminal agent to eliminate any remaining cysts in the intestine. Prevention strategies focus on improving sanitation, access to clean water, and personal hygiene practices to reduce the risk of infection.
Other Species[edit | edit source]
While Entamoeba histolytica is the primary pathogenic species, other species within the genus are considered commensals, meaning they live in the host without causing disease. These include Entamoeba dispar, which is morphologically identical to E. histolytica but non-pathogenic, and Entamoeba coli, a common inhabitant of the human gut.
Research and Public Health[edit | edit source]
Research on Entamoeba continues to focus on understanding the molecular mechanisms of pathogenicity, developing more effective treatments, and improving diagnostic methods. Public health efforts aim to reduce the incidence of amoebiasis through improved sanitation and education on hygiene practices.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD